Biopharmaceutical & MedTech Market Access | HEOR Strategy

Unlocking Market Access. Maximizing Value. Driving Impact.

In today’s evolving healthcare landscape, biopharmaceutical and MedTech success hinges on strategic market access, robust pricing models, and evidence-driven value demonstration. With over 25 years of global and U.S. experience in biopharmaceuticals and MedTech, Anthony Scot has led global initiatives in market expansion, reimbursement strategy, and Health Economics & Outcomes Research (HEOR). His expertise helps companies optimize access, accelerate adoption, and sustain commercial success.

Expertise in Market Access & HEOR

With a track record of driving market access for leading biopharma and MedTech organizations, Anthony Scot delivers comprehensive strategies that align innovation with payer expectations and healthcare system demands. His approach integrates economic modeling, real-world evidence, and stakeholder engagement to position products for success.

Core Capabilities

  • Pricing, Access & Reimbursement Strategy

    Developing competitive pricing models, innovative access frameworks, and payer engagement strategies to ensure optimal reimbursement and market penetration. Incorporating dynamic pricing strategies, risk-sharing agreements, and value-based contracting to enhance long-term sustainability.

  • HEOR & Real-World Evidence (RWE)

    Harnessing health economics, cost-effectiveness modeling, and real-world data to substantiate clinical and economic value, driving payer acceptance and policy inclusion. Utilizing patient-reported outcomes and long-term cost-benefit analyses to strengthen value demonstration.

  • Global Market Expansion & Commercial Strategy

    Navigating regional regulatory landscapes and payer ecosystems to craft market entry and growth strategies that optimize product adoption and reimbursement outcomes. Identifying key market differentiators and leveraging early access programs for accelerated entry.

  • Stakeholder & Payer Engagement

    Building compelling, evidence-backed value propositions that resonate with payers, healthcare providers, and decision-makers to accelerate access and uptake. Leading advisory board discussions and payer negotiations to drive alignment on value-based care models.

  • Regulatory & Policy Navigation

    Anticipating and adapting to global healthcare policy shifts, HTA (Health Technology Assessment) requirements, and evolving reimbursement frameworks to minimize access barriers and maximize market longevity. Providing strategic insights on policy trends and regulatory changes that impact pricing and reimbursement pathways.

  • Innovative Contracting & Market Access Execution

    Designing and implementing outcome-based reimbursement models, managed entry agreements, and risk-sharing frameworks that align with evolving payer expectations. Ensuring operational execution of access strategies through cross-functional coordination and real-time market feedback.

Delivering Lasting Market Success

Anthony’s strategic guidance ensures that biopharma and MedTech innovators don’t just enter markets—they thrive in them. Whether launching a breakthrough therapy, expanding into new geographies, or refining HEOR strategies, he provides actionable insights that drive sustained impact and revenue growth.